StonvexLoading…
StonvexStonvexStonvexCore line items from MMED's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-01-23 | Q1 2025 2025-01-24 |
|---|---|---|
Revenue | $2.27B | $1.99B |
Operating Income | $-97.00M | $2.00M |
Net Income | $-148.00M | $-41.00M |
EPS (Diluted) | $-0.59 | $-0.16 |
Total Assets | $4.34B | Not available |
Total Liabilities | $881.00M | Not available |
Cash & Equivalents | $10.00M | $10.00M |
Free Cash Flow OCF − CapEx | $-194.00M | $-79.00M |
Shares Outstanding | 252.81M | 252.81M |